Home
Monte Rosa Therapeutics, Inc.

Monte Rosa Therapeutics,... Market Share Analysis for November 2025

Pioneering Therapies for Cancer and Beyond – Our drug discovery platform is tailored to promote specific protein ubiquitination and subsequent proteasomal degradation of disease-causing, undruggable proteins, in essence leading to pharmacological protein knockout with high efficiency and accuracy.

Health > Biotechnology and Pharmaceuticals

Domainmonterosatx.com

Year Founded2019

Employees51 - 200

Annual Revenue$75M - $100M

Monte Rosa Therapeutics, Inc.

Monte Rosa Therapeutics, Inc. (including company regionals)

monterosatx.com

See more website traffic and engagement information

Monte Rosa Therapeutics, Inc. Revenue up to November 2025 is 75M - 100M

revenue generated by Monte Rosa Therapeutics, Inc. top domains

Monte Rosa Therapeutics, Inc. top domains revenue over 3 years

Revenue for Monte Rosa Therapeutics, Inc. top domains

monterosatx.com75M - 100M

See more with Sales Intelligence

Total visits to Monte Rosa Therapeutics, Inc.'s top domains

Understand Monte Rosa Therapeutics, Inc. market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

monterosatx.com20.9K

See more with Sales Intelligence

Avg. visit duration in Monte Rosa Therapeutics, Inc.'s top domains

Analyze Monte Rosa Therapeutics, Inc. engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

monterosatx.com00:01:00

See more with Sales Intelligence

Avg. pageviews on Monte Rosa Therapeutics, Inc.'s top domains

See how Monte Rosa Therapeutics, Inc. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

monterosatx.com2.13

See more with Sales Intelligence

Monte Rosa Therapeutics, Inc. top competitors by domain

Top similar sites in November 2025, ranked by their affinity

entradatx.comCompany NameEntrada TherapeuticsEmployees51 - 200HQUnited States, Massachusetts, BostonAnnual revenue$200M - $500MTotal visits8.3KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Monte Rosa Therapeutics, Inc.

These are the website technologies, by industry, used by Monte Rosa Therapeutics, Inc. top domains

Content Management System (4)

WordPress

Widget (3)

Twemoji

Advertising (2)

DoubleClick

eCommerce (2)

Squarespace Commerce

More Technologies

11

See all

News & Signals from Monte Rosa Therapeutics, Inc.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsMonte Rosa Therapeutics Inc. launches preclinical data on MRT-6160.Biotechnology company Monte Rosa Therapeutics has released preclinical data on MRT-6160, a molecular glue degrader (MGD) to treat autoimmune and inflammatory diseases.

NewsMonte Rosa Therapeutics Inc. attends event ACR Convergence 2025.Monte Rosa Therapeutics presents preclinical data at ACR Convergence 2025 on the potential of MRT-6160, a VAV1-directed molecular glue degrader, to treat immune-mediated diseases.

NewsMonte Rosa Therapeutics Inc. is developing protein degraders.Monte Rosa Therapeutics Inc, founded in Basel in 2018, can look forward to an upfront payment of US$120m for its second collaboration and licensing deal with Novartis AG to develop protein degraders.